Dyne Therapeutics DYN Stock
Dyne Therapeutics Price Chart
Dyne Therapeutics DYN Financial and Trading Overview
| Dyne Therapeutics stock price | 15.2 USD |
| Previous Close | 15.82 USD |
| Open | 16.03 USD |
| Bid | 11.34 USD x 200 |
| Ask | 19.36 USD x 200 |
| Day's Range | 15.09 - 16.03 USD |
| 52 Week Range | 12.43 - 27.31 USD |
| Volume | 2.5M USD |
| Avg. Volume | 2.73M USD |
| Market Cap | 2.84B USD |
| Beta (5Y Monthly) | 1.078 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.13 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 36 USD |
DYN Valuation Measures
| Enterprise Value | 2.17B USD |
| Trailing P/E | N/A |
| Forward P/E | -4.556423 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.5865974 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.064 |
Trading Information
Dyne Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.078 |
| 52-Week Change | 25.05% |
| S&P500 52-Week Change | 14.15% |
| 52 Week High | 27.31 USD |
| 52 Week Low | 12.43 USD |
| 50-Day Moving Average | 22.69 USD |
| 200-Day Moving Average | 19.64 USD |
DYN Share Statistics
| Avg. Volume (3 month) | 2.73M USD |
| Avg. Daily Volume (10-Days) | 3.09M USD |
| Shares Outstanding | 186.75M |
| Float | 186.24M |
| Short Ratio | 8.04 |
| % Held by Insiders | 0.23% |
| % Held by Institutions | 103.65% |
| Shares Short | 23.38M |
| Short % of Float | 16.00% |
| Short % of Shares Outstanding | 12.52% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -38.95% |
| Return on Equity (ttm) | -81.56% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -534804992 USD |
| Net Income Avi to Common (ttm) | -519404992 USD |
| Diluted EPS (ttm) | -3.13 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 898.48M USD |
| Total Cash Per Share (mrq) | 4.81 USD |
| Total Debt (mrq) | 233.35M USD |
| Total Debt/Equity (mrq) | 33.23 USD |
| Current Ratio (mrq) | 12.02 |
| Book Value Per Share (mrq) | 4.238 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -477819008 USD |
| Levered Free Cash Flow (ttm) | -317140736 USD |
Profile of Dyne Therapeutics
| Country | United States |
| State | MA |
| City | Waltham |
| Address | 1560 Trapelo Road |
| ZIP | 02451 |
| Phone | 781 786 8230 |
| Website | https://www.dyne-tx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 289 |
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Q&A For Dyne Therapeutics Stock
What is a current DYN stock price?
Dyne Therapeutics DYN stock price today per share is 15.2 USD.
How to purchase Dyne Therapeutics stock?
You can buy DYN shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dyne Therapeutics?
The stock symbol or ticker of Dyne Therapeutics is DYN.
Which industry does the Dyne Therapeutics company belong to?
The Dyne Therapeutics industry is Biotechnology.
How many shares does Dyne Therapeutics have in circulation?
The max supply of Dyne Therapeutics shares is 186.75M.
What is Dyne Therapeutics Price to Earnings Ratio (PE Ratio)?
Dyne Therapeutics PE Ratio is now.
What was Dyne Therapeutics earnings per share over the trailing 12 months (TTM)?
Dyne Therapeutics EPS is -3.13 USD over the trailing 12 months.
Which sector does the Dyne Therapeutics company belong to?
The Dyne Therapeutics sector is Healthcare.
Dyne Therapeutics DYN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27190.86 USD — |
+1.19
|
6.86B USD — | 27112.24 USD — | 27353.68 USD — | — - | 6.86B USD — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
13380.95 USD — |
+1.21
|
— — | 13341.63 USD — | 13459.93 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6947.64 USD — |
-0.26
|
— — | 6917.55 USD — | 6998.5 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1302.61 USD — |
-0.29
|
— — | 1298.55 USD — | 1311.62 USD — | — - | — — |
- {{ link.label }} {{link}}
